Payment overview · 2025
General Payments
$172.30
4 reported records · 3 companies
Healthcare provider profile · identity verified
Thomas Wayne Lewis, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · VERO BEACH, FL · NPI 1841268323
Verified facts
What the public records show
CMS Open Payments records show Thomas Wayne Lewis, M.D. received $172.30 in general payments during 2025 across 4 reported records.
Phathom Pharmaceuticals, Inc. accounted for 71.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Trelegy Ellipta.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 71 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $123.69 | 71.8% | 1 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $32.98 | 19.1% | 2 | 2025 |
| Kerecis Limited | Unresolved — no canonical attribution shown | $15.63 | 9.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $172.30 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $123.69 | 1 | 2025 |
Source payment records
|
|||||
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $32.98 | 2 | 2025 |
Source payment records
|
|||||
| Kerecis GraftGuide Normalized: kerecis graftguide |
Device | Kerecis Limited | $15.63 | 1 | 2025 |
Source payment records
|
|||||
| Kerecis SurgiClose Normalized: kerecis surgiclose |
Device | Kerecis Limited | $15.63 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 71 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
71 | 18 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 885 | 231 |
| Amlodipine Besylate | Amlodipine Besylate | 624 | 179 |
| Levothyroxine Sodium | Levothyroxine Sodium | 609 | 172 |
| Eliquis | Apixaban | 543 | 94 |
| Gabapentin | Gabapentin | 511 | 144 |
| Metformin Hcl | Metformin Hcl | 413 | 102 |
| Pantoprazole Sodium | Pantoprazole Sodium | 359 | 98 |
| Lisinopril | Lisinopril | 342 | 101 |
| Alprazolam | Alprazolam | 338 | 90 |
| Losartan Potassium | Losartan Potassium | 335 | 100 |
| Tamsulosin Hcl | Tamsulosin Hcl | 332 | 78 |
| Simvastatin | Simvastatin | 323 | 95 |
| Metoprolol Succinate | Metoprolol Succinate | 321 | 91 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 318 | 108 |
| Montelukast Sodium | Montelukast Sodium | 282 | 76 |
| Potassium Chloride | Potassium Chloride | 276 | 76 |
| Prednisone | Prednisone | 276 | 191 |
| Omeprazole | Omeprazole | 269 | 81 |
| Metoprolol Tartrate | Metoprolol Tartrate | 264 | 69 |
| Hydrochlorothiazide | Hydrochlorothiazide | 262 | 84 |
| Furosemide | Furosemide | 248 | 62 |
| Pravastatin Sodium | Pravastatin Sodium | 236 | 68 |
| Famotidine | Famotidine | 210 | 76 |
| Sertraline Hcl | Sertraline Hcl | 208 | 56 |
| Ezetimibe | Ezetimibe | 203 | 57 |
| Trazodone Hcl | Trazodone Hcl | 181 | 69 |
| Clopidogrel | Clopidogrel Bisulfate | 171 | 41 |
| Jardiance | Empagliflozin | 165 | 39 |
| Donepezil Hcl | Donepezil Hcl | 153 | 33 |
| Memantine Hcl | Memantine Hcl | 149 | 41 |
| Valsartan | Valsartan | 148 | 50 |
| Carvedilol | Carvedilol | 145 | 37 |
| Bumetanide | Bumetanide | 130 | 29 |
| Hydralazine Hcl | Hydralazine Hcl | 130 | 36 |
| Fluticasone Propionate | Fluticasone Propionate | 128 | 56 |
| Levetiracetam | Levetiracetam | 124 | 21 |
| Tramadol Hcl | Tramadol Hcl | 119 | 32 |
| Lorazepam | Lorazepam | 118 | 31 |
| Xarelto | Rivaroxaban | 115 | 17 |
| Allopurinol | Allopurinol | 111 | 32 |
| Doxycycline Hyclate | Doxycycline Hyclate | 111 | 93 |
| Myrbetriq | Mirabegron | 111 | 18 |
| Temazepam | Temazepam | 107 | 26 |
| Atenolol | Atenolol | 97 | 27 |
| Bupropion Xl | Bupropion Hcl | 95 | 31 |
| Metformin Hcl Er | Metformin Hcl | 94 | 32 |
| Fluoxetine Hcl | Fluoxetine Hcl | 91 | 31 |
| Ozempic | Semaglutide | 89 | 17 |
| Spironolactone | Spironolactone | 89 | 28 |
| Zolpidem Tartrate | Zolpidem Tartrate | 88 | 37 |
| Azithromycin | Azithromycin | 85 | 60 |
| Divalproex Sodium | Divalproex Sodium | 85 | 25 |
| Mirtazapine | Mirtazapine | 85 | 33 |
| Duloxetine Hcl | Duloxetine Hcl | 84 | 26 |
| Escitalopram Oxalate | Escitalopram Oxalate | 81 | 25 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 77 | 23 |
| Mounjaro | Tirzepatide | 75 | 18 |
| Finasteride | Finasteride | 72 | 23 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 71 | 18 |
| Sumatriptan Succinate | Sumatriptan Succinate | 66 | suppressed |
| Clonazepam | Clonazepam | 65 | 17 |
| Quetiapine Fumarate | Quetiapine Fumarate | 63 | 17 |
| Clonidine Hcl | Clonidine Hcl | 62 | 11 |
| Meloxicam | Meloxicam | 62 | 24 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 62 | 15 |
| Entresto | Sacubitril/Valsartan | 60 | suppressed |
| Trulicity | Dulaglutide | 58 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 56 | 33 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 56 | 16 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 54 | 43 |
| Synthroid | Levothyroxine Sodium | 54 | 15 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 53 | 37 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 53 | 16 |
| Topiramate | Topiramate | 52 | 12 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 51 | suppressed |
| Baclofen | Baclofen | 51 | 12 |
| Dicyclomine Hcl | Dicyclomine Hcl | 50 | suppressed |
| Glimepiride | Glimepiride | 49 | 16 |
| Nebivolol Hcl | Nebivolol Hcl | 49 | 13 |
| Valacyclovir | Valacyclovir Hcl | 49 | 21 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 48 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 48 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 47 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 45 | 38 |
| Breo Ellipta | Fluticasone/Vilanterol | 45 | 13 |
| Fluconazole | Fluconazole | 45 | 24 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 45 | suppressed |
| Latanoprost | Latanoprost | 45 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 45 | 18 |
| Buspirone Hcl | Buspirone Hcl | 44 | 16 |
| Lamotrigine | Lamotrigine | 44 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 44 | 16 |
| Cefdinir | Cefdinir | 43 | 38 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 43 | 11 |
| Farxiga | Dapagliflozin Propanediol | 43 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 42 | 13 |
| Mupirocin | Mupirocin | 41 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 40 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 40 | 11 |
| Procrit | Epoetin Alfa | 39 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 38 | suppressed |
| Eszopiclone | Eszopiclone | 37 | 12 |
| Glipizide Er | Glipizide | 37 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 36 | 20 |
| Doxazosin Mesylate | Doxazosin Mesylate | 36 | 12 |
| Midodrine Hcl | Midodrine Hcl | 36 | 12 |
| Namzaric | Memantine Hcl/Donepezil Hcl | 36 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 36 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 35 | 11 |
| Celecoxib | Celecoxib | 34 | suppressed |
| Estradiol | Estradiol | 33 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 32 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 32 | 23 |
| Terazosin Hcl | Terazosin Hcl | 32 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 31 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 31 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 30 | suppressed |
| Methotrexate | Methotrexate Sodium | 30 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 30 | 11 |
| Aptiom | Eslicarbazepine Acetate | 29 | suppressed |
| Chlorthalidone | Chlorthalidone | 29 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 29 | 23 |
| Enalapril Maleate | Enalapril Maleate | 29 | suppressed |
| Linzess | Linaclotide | 29 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 29 | 21 |
| Irbesartan | Irbesartan | 28 | suppressed |
| Tradjenta | Linagliptin | 28 | suppressed |
| Xifaxan | Rifaximin | 28 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 27 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 27 | 15 |
| Repatha Sureclick | Evolocumab | 27 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 26 | suppressed |
| Diazepam | Diazepam | 26 | 13 |
| Digoxin | Digoxin | 26 | suppressed |
| Methylprednisolone | Methylprednisolone | 26 | 19 |
| Nifedipine Er | Nifedipine | 26 | suppressed |
| Pregabalin | Pregabalin | 26 | suppressed |
| Primidone | Primidone | 25 | suppressed |
| Sotalol | Sotalol Hcl | 25 | suppressed |
| Acyclovir | Acyclovir | 24 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 24 | 12 |
| Methocarbamol | Methocarbamol | 24 | suppressed |
| Budesonide | Budesonide | 23 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 23 | 20 |
| Jantoven | Warfarin Sodium | 23 | suppressed |
| Nateglinide | Nateglinide | 23 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 23 | 17 |
| Colchicine | Colchicine | 22 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 22 | suppressed |
| Amoxicillin | Amoxicillin | 21 | 15 |
| Glipizide | Glipizide | 21 | suppressed |
| Januvia | Sitagliptin Phosphate | 21 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 21 | 18 |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Risperidone | Risperidone | 21 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 20 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 20 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 20 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 20 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 20 | suppressed |
| Nystatin | Nystatin | 20 | 16 |
| Oxcarbazepine | Oxcarbazepine | 20 | suppressed |
| Fenofibrate | Fenofibrate | 19 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 19 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 19 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 19 | 19 |
| Telmisartan | Telmisartan | 19 | suppressed |
| Lansoprazole | Lansoprazole | 18 | suppressed |
| Livalo | Pitavastatin Calcium | 18 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 18 | suppressed |
| Ondansetron Odt | Ondansetron | 18 | 17 |
| Alendronate Sodium | Alendronate Sodium | 17 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 17 | suppressed |
| Scopolamine | Scopolamine | 17 | suppressed |
| Vascepa | Icosapent Ethyl | 17 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 16 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 16 | suppressed |
| Ertapenem | Ertapenem Sodium | 16 | suppressed |
| Ketoconazole | Ketoconazole | 16 | 11 |
| Labetalol Hcl | Labetalol Hcl | 16 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 16 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 16 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 16 | suppressed |
| Hydrocortisone | Hydrocortisone | 15 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 15 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 15 | 11 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 15 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 15 | suppressed |
| Restasis | Cyclosporine | 15 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 15 | suppressed |
| Zosyn | Piperacillin-Tazo-Dextrose,iso | 15 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 14 | suppressed |
| Calcitriol | Calcitriol | 14 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 14 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 14 | suppressed |
| Levemir Flexpen | Insulin Detemir | 14 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 13 | suppressed |
| Klor-Con 10 | Potassium Chloride | 13 | suppressed |
| Lactulose | Lactulose | 13 | suppressed |
| Lubiprostone | Lubiprostone | 13 | suppressed |
| Metolazone | Metolazone | 13 | suppressed |
| Ranolazine Er | Ranolazine | 13 | suppressed |
| Erythromycin | Erythromycin Base | 12 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | 12 |
| Lovastatin | Lovastatin | 12 | suppressed |
| Metronidazole | Metronidazole | 12 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 12 | suppressed |
| Novolin R | Insulin Regular, Human | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Silodosin | Silodosin | 12 | suppressed |
| Timolol Maleate | Timolol Maleate | 12 | suppressed |
| Brilinta | Ticagrelor | 11 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 11 | suppressed |
| Ibuprofen | Ibuprofen | 11 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 11 | suppressed |
| Mirabegron Er | Mirabegron | 11 | suppressed |
| Olanzapine | Olanzapine | 11 | suppressed |
| Phenobarbital | Phenobarbital | 11 | suppressed |
| Testosterone | Testosterone | 11 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $172.30 · 4 records | Phathom Pharmaceuticals, Inc. | Kerecis GraftGuide, Kerecis SurgiClose, TRELEGY ELLIPTA, VOQUEZNA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Trelegy Ellipta play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error